Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 81

1.

An Unusual Vesiculopustular Eruption: Answer.

Van-de-Velde V, Matthews AG, Biswas A.

Am J Dermatopathol. 2018 Sep;40(9):703. doi: 10.1097/DAD.0000000000001099. No abstract available.

PMID:
30119105
2.

An Unusual Vesiculopustular Eruption: Challenge.

Van-de-Velde V, Matthews AG, Biswas A.

Am J Dermatopathol. 2018 Sep;40(9):e124-e125. doi: 10.1097/DAD.0000000000001100. No abstract available.

PMID:
29341961
3.

Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trial.

Lee JD, Nunes EV Jr, Novo P, Bachrach K, Bailey GL, Bhatt S, Farkas S, Fishman M, Gauthier P, Hodgkins CC, King J, Lindblad R, Liu D, Matthews AG, May J, Peavy KM, Ross S, Salazar D, Schkolnik P, Shmueli-Blumberg D, Stablein D, Subramaniam G, Rotrosen J.

Lancet. 2018 Jan 27;391(10118):309-318. doi: 10.1016/S0140-6736(17)32812-X. Epub 2017 Nov 14.

4.

A randomized placebo-controlled trial of N-acetylcysteine for cannabis use disorder in adults.

Gray KM, Sonne SC, McClure EA, Ghitza UE, Matthews AG, McRae-Clark AL, Carroll KM, Potter JS, Wiest K, Mooney LJ, Hasson A, Walsh SL, Lofwall MR, Babalonis S, Lindblad RW, Sparenborg S, Wahle A, King JS, Baker NL, Tomko RL, Haynes LF, Vandrey RG, Levin FR.

Drug Alcohol Depend. 2017 Aug 1;177:249-257. doi: 10.1016/j.drugalcdep.2017.04.020. Epub 2017 Jun 10.

5.

Comparing adult cannabis treatment-seekers enrolled in a clinical trial with national samples of cannabis users in the United States.

McClure EA, King JS, Wahle A, Matthews AG, Sonne SC, Lofwall MR, McRae-Clark AL, Ghitza UE, Martinez M, Cloud K, Virk HS, Gray KM.

Drug Alcohol Depend. 2017 Jul 1;176:14-20. doi: 10.1016/j.drugalcdep.2017.02.024. Epub 2017 May 10.

6.

Causes of death and expected years of life lost among treated opioid-dependent individuals in the United States and Taiwan.

Chang KC, Wang JD, Saxon A, Matthews AG, Woody G, Hser YI.

Int J Drug Policy. 2017 May;43:1-6. doi: 10.1016/j.drugpo.2016.12.003. Epub 2017 Feb 1.

7.

Distinctive Trajectories of Opioid Use Over an Extended Follow-up of Patients in a Multisite Trial on Buprenorphine + Naloxone and Methadone.

Hser YI, Huang D, Saxon AJ, Woody G, Moskowitz AL, Matthews AG, Ling W.

J Addict Med. 2017 Jan/Feb;11(1):63-69. doi: 10.1097/ADM.0000000000000274.

8.

Opioid, NSAID, and OTC Analgesic Medications for Dental Procedures: PEARL Network Findings.

Wong YJ, Keenan J, Hudson K, Bryan H, Naftolin F, Thompson VP, Craig RG, Vena D, Collie D, Wu H, Matthews AG, Grill AC, Curro FA.

Compend Contin Educ Dent. 2016 Nov/Dec;37(10):710-718.

PMID:
27875056
9.

Regulated large-scale nucleosome density patterns and precise nucleosome positioning correlate with V(D)J recombination.

Pulivarthy SR, Lion M, Kuzu G, Matthews AG, Borowsky ML, Morris J, Kingston RE, Dennis JH, Tolstorukov MY, Oettinger MA.

Proc Natl Acad Sci U S A. 2016 Oct 18;113(42):E6427-E6436. Epub 2016 Oct 3.

10.

Buprenorphine + naloxone plus naltrexone for the treatment of cocaine dependence: the Cocaine Use Reduction with Buprenorphine (CURB) study.

Ling W, Hillhouse MP, Saxon AJ, Mooney LJ, Thomas CM, Ang A, Matthews AG, Hasson A, Annon J, Sparenborg S, Liu DS, McCormack J, Church S, Swafford W, Drexler K, Schuman C, Ross S, Wiest K, Korthuis PT, Lawson W, Brigham GS, Knox PC, Dawes M, Rotrosen J.

Addiction. 2016 Aug;111(8):1416-27. doi: 10.1111/add.13375. Epub 2016 Apr 21.

11.

Statistical Monitoring in Clinical Trials: Best Practices for Detecting Data Anomalies Suggestive of Fabrication or Misconduct.

Knepper D, Lindblad AS, Sharma G, Gensler GR, Manukyan Z, Matthews AG, Seifu Y.

Ther Innov Regul Sci. 2016 Mar;50(2):144-154. doi: 10.1177/2168479016630576.

PMID:
30227005
12.

Long-term outcomes after randomization to buprenorphine/naloxone versus methadone in a multi-site trial.

Hser YI, Evans E, Huang D, Weiss R, Saxon A, Carroll KM, Woody G, Liu D, Wakim P, Matthews AG, Hatch-Maillette M, Jelstrom E, Wiest K, McLaughlin P, Ling W.

Addiction. 2016 Apr;111(4):695-705. doi: 10.1111/add.13238. Epub 2016 Jan 13.

13.

Case Presentations Demonstrating Periodontal Treatment Variation: PEARL Network.

Curro FA, Grill AC, Matthews AG, Martin J, Kalenderian E, Craig RG, Naftolin F, Thompson VP.

Compend Contin Educ Dent. 2015 Jun;36(6):432-40.

PMID:
26053783
14.

Painful ulcers.

Lovgren ML, Matthews AG, Torley D.

Clin Exp Dermatol. 2016 Jan;41(1):109-11. doi: 10.1111/ced.12688. Epub 2015 May 21. No abstract available.

PMID:
25997839
15.

Merkel cell carcinoma in Scotland 2000-10.

Samuel RJ, Matthews AG, Holme SA.

Br J Dermatol. 2015 Oct;173(4):1073-5. doi: 10.1111/bjd.13869. Epub 2015 Aug 30. No abstract available.

PMID:
25919409
16.

Compound heterozygous mutation of Rag1 leading to Omenn syndrome.

Matthews AG, Briggs CE, Yamanaka K, Small TN, Mooster JL, Bonilla FA, Oettinger MA, Butte MJ.

PLoS One. 2015 Apr 7;10(4):e0121489. doi: 10.1371/journal.pone.0121489. eCollection 2015.

17.

Unusual nodules around a surgical wound.

Matthews AG, Humphreys CA, Muinonen-Martin AJ, Gangopadhyay M, Holmes S.

Clin Exp Dermatol. 2014 Oct;39(7):847-9. doi: 10.1111/ced.12419. Epub 2014 Sep 5. No abstract available.

PMID:
25196728
18.

Achieving cannabis cessation -- evaluating N-acetylcysteine treatment (ACCENT): design and implementation of a multi-site, randomized controlled study in the National Institute on Drug Abuse Clinical Trials Network.

McClure EA, Sonne SC, Winhusen T, Carroll KM, Ghitza UE, McRae-Clark AL, Matthews AG, Sharma G, Van Veldhuisen P, Vandrey RG, Levin FR, Weiss RD, Lindblad R, Allen C, Mooney LJ, Haynes L, Brigham GS, Sparenborg S, Hasson AL, Gray KM.

Contemp Clin Trials. 2014 Nov;39(2):211-23. doi: 10.1016/j.cct.2014.08.011. Epub 2014 Aug 30.

19.

Hydroxycarbamide-induced cutaneous ulceration with a difference.

Matthews AG, Wylie G.

Br J Dermatol. 2014 Dec;171(6):1572-4. doi: 10.1111/bjd.13151. Epub 2014 Nov 2. No abstract available.

PMID:
24888252
20.

Internet-delivered treatment for substance abuse: a multisite randomized controlled trial.

Campbell AN, Nunes EV, Matthews AG, Stitzer M, Miele GM, Polsky D, Turrigiano E, Walters S, McClure EA, Kyle TL, Wahle A, Van Veldhuisen P, Goldman B, Babcock D, Stabile PQ, Winhusen T, Ghitza UE.

Am J Psychiatry. 2014 Jun;171(6):683-90. doi: 10.1176/appi.ajp.2014.13081055. Erratum in: Am J Psychiatry. 2014 Dec 1;171(12):1338.

Supplemental Content

Loading ...
Support Center